
Fierce Pharma Asia—Former China FDA head under investigation; Daiichi pulls ADC filing
China's anti-graft watchdog is investigating Bi Jingquan, the former head of the China Food and Drug Administration. Daiichi Sankyo, along with partner Merck & Co., has pulled an FDA approval filing for an antibody-drug conjugate (ADC) cancer …